{"symbol":"BSX","fiscalQuarter":"Q1-2024","reportDate":"2024-04-24","reportTime":"BMO","status":"reported","company":{"name":"Boston Scientific Corporation","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/BSX/earnings/Q1-2024","postBrief":{"headline":"Boston Scientific Misses on EPS, Stock Up 5.68%","keyNumbers":[{"metric":"EPS","actual":"$0.33","expected":"N/A","surprise":"-35.17%"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management highlighted ongoing investments in innovation and product development.","They acknowledged the challenges faced in the current market environment."],"summary":"Overall, management expressed confidence in their long-term strategy despite the EPS miss. They emphasized their commitment to growth and innovation."},"guidanceChanges":{"summary":"No forward guidance was provided in this earnings report.","changes":[]},"whatItMeans":"Boston Scientific's Q1 2024 earnings report showed a significant EPS miss, which typically raises concerns among investors. However, the stock rose by 5.68%, likely driven by positive sentiment around their long-term strategy and ongoing investments in innovation. This reaction suggests that investors may be looking beyond the short-term earnings results.","metaDescription":"Boston Scientific (BSX) Q1 2024 earnings: EPS missed expectations. Stock up 5.68%. Full breakdown."}}